News

Inflammatory Marker Predicts ALS Disability and Survival, Supporting Development of Neuraltus Therapy NP001

Measuring blood levels of the inflammatory marker C-reactive protein (CRP) in patients with amyotrophic lateral sclerosis (ALS) can help physicians track the disease, according to an Italian study of 394 people with ALS. Neuraltus Pharmaceuticals of San Bruno, Calif., believes this study further supports the idea that ALS may respond to inflammation-modulating…

Job Exposure to Extremely Low-Frequently Magnetic Fields Increases ALS Risk, Dutch Study Shows

Occupational exposure to extremely low-frequency magnetic fields (ELF-MFs) could trigger amyotrophic lateral sclerosis (ALS), a Dutch study shows. The study, “Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort,” appeared in the journal Occupational & Environmental Medicine. Given that only 5 to 10 percent of ALS cases are hereditary, scientists…

ALS Patients Have No Distinct Swallowing Pattern, Which May Increase Choking Risk, Study Suggests

Amyotrophic lateral sclerosis (ALS) patients follow no distinct swallowing pattern, and this may account for the development of swallowing difficulties over time that can lead to life-threatening choking, a study reports. The research, “The Importance Of The Reproducibility Of Oropharyngeal Swallowing In Amyotrophic Lateral Sclerosis: An Electrophysiological Study,” was…

ALS and Schizophrenia Come from Same Genetic Roots, Study Confirms

Schizophrenia in relatives of amyotrophic lateral sclerosis (ALS) patients is caused by shared genetic factors that increase the risk of both conditions, researchers confirmed. This prompted them to contend that scientists should view ALS as a disease of brain connections, rather than of individual brain cells. The way to treat…